Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14854 | 676 | 29.9 | 57% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1046 | 9602 | OPIOID GROWTH FACTOR//OPIOID GROWTH FACTOR RECEPTOR//BETA ENDORPHIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EA 4468GERIATR | Address | 6 | 100% | 1% | 4 |
2 | EUROPEAN STUDY DIABET CEED | Address | 3 | 60% | 0% | 3 |
3 | BETA ENDORPHIN LIKE IMMUNOREACTIVITY | Author keyword | 2 | 67% | 0% | 2 |
4 | OPIOID EFFECT | Author keyword | 2 | 67% | 0% | 2 |
5 | OPIUM SMOKING | Author keyword | 2 | 67% | 0% | 2 |
6 | PHARMACOL MED PARIS SUD | Address | 2 | 67% | 0% | 2 |
7 | PROOPIOMELANOCORTIN GENE EXPRESSION | Author keyword | 2 | 67% | 0% | 2 |
8 | OPIOID MU RECEPTOR | Author keyword | 2 | 33% | 1% | 5 |
9 | OPIOID MU RECEPTORS | Author keyword | 2 | 28% | 1% | 5 |
10 | ENDOCRINOL DIABET DIS NUTR POLE NUDE | Address | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BETA ENDORPHIN LIKE IMMUNOREACTIVITY | 2 | 67% | 0% | 2 | Search BETA+ENDORPHIN+LIKE+IMMUNOREACTIVITY | Search BETA+ENDORPHIN+LIKE+IMMUNOREACTIVITY |
2 | OPIOID EFFECT | 2 | 67% | 0% | 2 | Search OPIOID+EFFECT | Search OPIOID+EFFECT |
3 | OPIUM SMOKING | 2 | 67% | 0% | 2 | Search OPIUM+SMOKING | Search OPIUM+SMOKING |
4 | PROOPIOMELANOCORTIN GENE EXPRESSION | 2 | 67% | 0% | 2 | Search PROOPIOMELANOCORTIN+GENE+EXPRESSION | Search PROOPIOMELANOCORTIN+GENE+EXPRESSION |
5 | OPIOID MU RECEPTOR | 2 | 33% | 1% | 5 | Search OPIOID+MU+RECEPTOR | Search OPIOID+MU+RECEPTOR |
6 | OPIOID MU RECEPTORS | 2 | 28% | 1% | 5 | Search OPIOID+MU+RECEPTORS | Search OPIOID+MU+RECEPTORS |
7 | GLUCAGON AND INSULIN | 1 | 100% | 0% | 2 | Search GLUCAGON+AND+INSULIN | Search GLUCAGON+AND+INSULIN |
8 | GLUCOSE TRANSPORTER SUBTYPE 4 | 1 | 33% | 0% | 2 | Search GLUCOSE+TRANSPORTER+SUBTYPE+4 | Search GLUCOSE+TRANSPORTER+SUBTYPE+4 |
9 | A1 AR | 1 | 50% | 0% | 1 | Search A1+AR | Search A1+AR |
10 | ACTH LIKE PEPTIDES | 1 | 50% | 0% | 1 | Search ACTH+LIKE+PEPTIDES | Search ACTH+LIKE+PEPTIDES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYPERENDORPHINEMIA | 12 | 86% | 1% | 6 |
2 | ACTH22 39 | 6 | 100% | 1% | 4 |
3 | MYOBLAST C2C12 CELLS | 6 | 100% | 1% | 4 |
4 | LIPOTROPIN | 4 | 21% | 3% | 18 |
5 | INSULIN SECRETAGOGUE | 3 | 57% | 1% | 4 |
6 | OPIOID MU RECEPTOR | 3 | 50% | 1% | 4 |
7 | OPIUM ADDICTION | 2 | 67% | 0% | 2 |
8 | ANAEROBIC EXERCISE | 2 | 12% | 2% | 14 |
9 | B ENDORPHIN | 1 | 100% | 0% | 2 |
10 | LIPOTROPIN PLASMA LEVELS | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The effect of physical therapy on beta-endorphin levels | 2007 | 26 | 102 | 32% |
Levels of beta-endorphin in response to exercise and overtraining | 2008 | 7 | 64 | 53% |
ENDORPHINS AND EXERCISE - PHYSIOLOGICAL-MECHANISMS AND CLINICAL IMPLICATIONS | 1990 | 145 | 116 | 19% |
OPIOID-PEPTIDES AND METABOLIC-REGULATION | 1988 | 31 | 77 | 65% |
A ROLE FOR BETA-ENDORPHIN IN THE PATHOGENESIS OF HUMAN OBESITY | 1991 | 14 | 37 | 57% |
METABOLIC EFFECTS OF OPIATES AND OPIOID-PEPTIDES | 1994 | 8 | 31 | 58% |
Opioid mu-receptors as new target for insulin resistance | 2013 | 1 | 62 | 26% |
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities | 2006 | 14 | 60 | 27% |
THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN OBESITY | 1995 | 37 | 79 | 16% |
Coronary Artery Disease and Its Risk Factors Status in Iran: A Review | 2011 | 6 | 58 | 12% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EA 4468GERIATR | 6 | 100% | 0.6% | 4 |
2 | EUROPEAN STUDY DIABET CEED | 3 | 60% | 0.4% | 3 |
3 | PHARMACOL MED PARIS SUD | 2 | 67% | 0.3% | 2 |
4 | ENDOCRINOL DIABET DIS NUTR POLE NUDE | 1 | 100% | 0.3% | 2 |
5 | ST JULIEN UNIV HOSP | 1 | 40% | 0.3% | 2 |
6 | AFINEJHAD HOSP | 1 | 50% | 0.1% | 1 |
7 | ENDOCRINOL DIABET NUTR RELATED DIS NUDE UNIT | 1 | 50% | 0.1% | 1 |
8 | HARBOR GEN HOSP MED | 1 | 50% | 0.1% | 1 |
9 | INSERM MEDU1027 | 1 | 50% | 0.1% | 1 |
10 | KOVLER VIRAL ONCOL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000200398 | HYPOXIC SURVIVAL//AIRTIGHT CHAMBER//ANIMAL CAT |
2 | 0.0000162100 | NOR BINALTORPHAMINE//MINNESOTA OBES//NEUROPSYCHOL DOCTORAL SUB PROGRAM |
3 | 0.0000135565 | GLIBORNURIDE//MALMO GEN HOSP ENDOCRINOL//ALCOHOL TOLERANCE |
4 | 0.0000114115 | OPIAD//SECT CANC PAIN MANAGEMENT//AGR FO TRY 310C |
5 | 0.0000103389 | DADLE//MOL BIOL DRUG//KEY DISCIPLINE CELL BIOL |
6 | 0.0000097972 | OVERTRAINING//OVERREACHING//STALENESS |
7 | 0.0000090649 | SUBSTANCE P ENDOPEPTIDASE//ENKEPHALINS AND PAIN MODULATION//HETEROCYCLIC ANTIPSYCHOTICS |
8 | 0.0000090410 | PROENKEPHALIN//PROENKEPHALINS//PRO ENKEPHALIN |
9 | 0.0000087127 | PROOPIOMELANOCORTIN//PROOPIOCORTIN//PROOPIOMELANOTROPIN |
10 | 0.0000076117 | CLIN EXPT INVEST UNIT//ISLET OF LANGERHANS RAT//INDOMETHACIN THERAPY |